NCT05414591

Pharmacokinetics and Safety Following Administration of DWP16001

A Phase 1 Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics After Administration of DWP16001 Drug A and DWP16001 Drug B in Healthy Adult Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 38 (actual)
• Sponsor: Daewoong Pharmaceutical Co. LTD. · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Accepted

Summary

To compare and evaluate the safety and pharmacokinetic characteristics after administration of DWP16001 Drug A and DWP16001 Drug B in healthy adult volunteers

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	DWP16001 drug A	1 tablet, Oral, once daily single dose
DRUG	DWP16001 drug B	3 tablet, Oral, once daily single dose

Timeline

• Start date: 2021-05-01
• Primary completion: 2021-08-01
• Completion: 2021-08-01
• First posted: 2022-06-10
• Last updated: 2022-07-13

Locations

1 site across 1 country: South Korea